Researchers from University of Nebraska Medical Center Report Details of New Studies and Findings in the Area of Managed Care (Addressing Healthcare Disparities and Managed Care Considerations With Continuous Glucose Monitoring): Managed Care

2023 APR 26 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Researchers detail new data in Managed Care. According to news reporting originating from Omaha, Nebraska, by NewsRx editors, the research stated, “About 37 million people in the United States have diabetes. Diabetes-related complications are costly and associated with substantial morbidity.”

Financial support for this research came from educational grant from Abbott Diabetes Care Inc.

Our news editors obtained a quote from the research from the University of Nebraska Medical Center, “By improving glucose control, continuous glucose monitoring (CGM) can reduce costs due to diabetes-related hospitalizations, hypoglycemia, and diabetic ketoacidosis. However, people of color and low socioeconomic status, populations with disproportionately high prevalence of diabetes, face significant inequity in accessing CGM technology. Potential reasons for CGM inequity include implicit bias and differences in coverage between commercial and government insurance. Recent changes to Medicare CGM eligibility criteria have eliminated blood glucose monitoring requirements. However, cost and CGM coverage requirements remain as barriers to the recommended use of this technology as defined in current clinical practice guidelines. Coverage expansion from durable medical equipment to the pharmacy benefit may improve access. Other strategies to optimize CGM utility overall include integrating CGM data directly into electronic health records for population health management and diabetes control performance measures based on CGM data in value-based contracts (VBCs).”

According to the news editors, the research concluded: “VBCs may encourage real-world data generation which in turn may bolster stakeholder support for the equitable use and coverage of CGM in diabetes management.”

This research has been peer-reviewed.

For more information on this research see: Addressing Healthcare Disparities and Managed Care Considerations With Continuous Glucose Monitoring. The American Journal of Managed Care, 2022;28. The American Journal of Managed Care can be contacted at: Managed Care & Healthcare Communications Llc, 666 Plainsboro Rd, Ste 300, Plainsboro, NJ 08536, USA.

The news editors report that additional information may be obtained by contacting Carrie McAdam Marx, University of Nebraska Medical Center, College of Pharmacy, Dept. of Pharmacy Practice and Sciences, Omaha, NE 68198, United States.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.37765/ajmc.2022.89215. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)